Chinese Pharma Firm Raises $150M From Private Investors
Chinese biopharmaceutical company CStone Pharmaceuticals Co. Ltd., which focuses on developing treatments related to oncology among other therapeutic areas, has raised $150 million from a group of private investors including Oriza...To view the full article, register now.
Already a subscriber? Click here to view full article